Buscar
Mostrando ítems 31-40 de 1902
Non-uremic calciphylaxis and Chagas diseaseCalcifilaxis no urémica y enfermedad de Chagas
(Elsevier, 2014-04)
We describe the first report of calciphylaxis in a patient seropositive for Chagas disease, which is known to lead to several immunological disturbances.
Trypanosoma Cruzi I Genotype Among Isolates from Chronic Chagasic Patients followed at the Evandro Chagas National Institute of Infectious Diseases (Fiocruz, Brazil)
(Sociedade Brasileira de Protozoologia, 2023)
Discrete typing units of Trypanosoma cruzi detected by real-time PCR in Chilean patients with chronic Chagas cardiomyopathy
(Elsevier B.V., 2018)
© 2018 Elsevier B.V. Chagas disease is a major public health problem in Latin America and has spread to other countries due to immigration of infected persons. 10–30% of patients with chronic Chagas disease will develop ...
The discovery of Chagas disease (1908-1909): great successes and certain misunderstandings and challenges
(Sociedade Brasileira de Medicina Tropical - SBMT, 2015)
Chagas Disease (Trypanosoma cruzi)
(Oxford University Press, 2018)
Chagas disease (CD), or American trypanosomiasis, is cuased by the hemoflagelate parasite Trypanosoma cruzi. CD is named for the Brazilian physician Carlos Chagas, who discovered the disease in 1909. Patients withc CD nor ...
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
(Instituto Oswaldo Cruz, Ministério da Saúde, 2009)
Among the pathophysiological derangements operating in the chronic phase of Chagas disease, parasite persistence is likely to constitute the main mechanism of myocardial injury in patients with chronic chagasic cardiomyopathy. ...